BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31371408)

  • 1. ALK-positive histiocytosis with
    Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
    Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
    [No Abstract]   [Full Text] [Related]  

  • 2. Localised ALK-positive histiocytosis in lung with EML4::ALK fusion.
    Zou L; Lu T; Li M; Wang A; Zhang Z; Pan B; Sun J
    Pathology; 2024 Jun; 56(4):604-606. PubMed ID: 38097451
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast.
    Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K
    Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated ALK-positive histiocytosis with
    Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
    Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma.
    Ise M; Kageyama H; Araki A; Itami M
    Leuk Lymphoma; 2019 Feb; 60(2):493-497. PubMed ID: 30187817
    [No Abstract]   [Full Text] [Related]  

  • 7. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
    Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
    Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
    Lucas CG; Gilani A; Solomon DA; Liang X; Maher OM; Chamyan G; Kleinschmidt-Demasters BK; Perry A
    Acta Neuropathol; 2019 Aug; 138(2):335-337. PubMed ID: 31119374
    [No Abstract]   [Full Text] [Related]  

  • 9. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
    Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
    Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel
    Shimizu N; Akashi Y; Fujii T; Shiono H; Yane K; Kitahara T; Ohta Y; Kakudo K; Wakasa T
    Anticancer Res; 2019 Jan; 39(1):413-420. PubMed ID: 30591488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ALK positive histiocytosis with multiple system involvement: report of a case].
    Yao S; Zhang F; Chen Y; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):495-497. PubMed ID: 38678335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour.
    Maruggi M; Malicki DM; Levy ML; Crawford JR
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344149
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma.
    Wolter NE; Ngan B; Whitlock JA; Dickson BC; Propst EJ
    Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109585. PubMed ID: 31351348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor Regarding "Local ALK-Positive Histiocytosis with Unusual Morphology and Novel
    Soylemez Akkurt T; Dur Karasayar AH; Gurbuz BC; Altınay S; Yuzkan S; Baskan F
    Int J Surg Pathol; 2023 Oct; 31(7):1426-1429. PubMed ID: 36471533
    [No Abstract]   [Full Text] [Related]  

  • 16. Notable therapeutic response in a patient with systemic juvenile xanthogranuloma with KIF5B-ALK fusion.
    Sugiyama M; Hirabayashi S; Ishi Y; Kikuchi J; Ishikura A; Motegi H; Ueda Y; Sawai S; Hara K; Terashita Y; Cho Y; Takakuwa E; Honda S; Yamaguchi S; Kinoshita I; Manabe A
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29227. PubMed ID: 34245207
    [No Abstract]   [Full Text] [Related]  

  • 17. Subependymal giant cell astrocytoma harboring a PRRC2B-ALK fusion: A case report.
    Tsurubuchi T; Nakano Y; Hirato J; Yoshida A; Muroi A; Sakamoto N; Alexander Z; Matsuda M; Ishikawa E; Kohno T; Yoshioka T; Honda-Kitahara M; Ichimura K; Yamamoto T; Matsumura A
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27995. PubMed ID: 31502411
    [No Abstract]   [Full Text] [Related]  

  • 18. SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing.
    Hou X; Xu H; Chen L
    J Thorac Oncol; 2019 Apr; 14(4):e72-e73. PubMed ID: 30922581
    [No Abstract]   [Full Text] [Related]  

  • 19. ALK-Positive Histiocytosis: A Case Report and Literature Review.
    Jaber OI; Jarrah DA; Hiasat M; Hussaini MA
    Turk Patoloji Derg; 2021; 37(2):172-177. PubMed ID: 33973641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system.
    Rossi S; Gessi M; Barresi S; Tamburrini G; Giovannoni I; Ruggiero A; Colafati GS; Frassanito P; Carboni A; Alexandre A; Cacchione A; Trombatore P; Diomedi-Camassei F; Gaspari S; Gianno F; Marras CE; Cecinati V; Carai A; Mastronuzzi A; Alaggio R
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):878-881. PubMed ID: 34048085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.